MTOR and autism: We used lymphoblastoid cell lines from patients with autism of unknown etiology obtained from the AGRE collection and the SSC to test the hypothesis that dysregulated PI3K/mTOR signaling is a shared pathological mechanism, treatment target, and biomarker in autism.